Share

Cell Press sponsors free neuroscience symposium Monday in Paris

Public meeting offered in celebration of 20th anniversary of Neuron

CAMBRIDGE, Mass., USA (October 17, 2008) – Cell Press, an imprint of Elsevier, will co-sponsor a free, public Neuroscience symposium on Monday, 20 October, in Paris to celebrate the 20th anniversary of its prestigious journal, Neuron.

"The Impact of Neuroscience on Society" will run from 9:30 a.m. to 4:30 p.m. inside the city's Collège de France. Cell Press offers this meeting in conjunction with Fondation IPSEN, based in Paris, and Massachusetts General Hospital, of Boston, Mass., USA.

Since 1988, Neuron has been at the forefront of publishing the most exciting research in all areas of the neurosciences. This meeting celebrates the contribution of all the authors, reviewers and readers around the world who have contributed to the success of Neuron.

The past two decades have been characterized by explosive growth and excitement within the neurosciences, with powerful new tools bringing us breathtaking new windows into the mysteries of the brain. Neuron has been proud to be a part of communicating so many of these discoveries. The goal of this special one-day symposium is to spotlight the tremendous contributions and implications that modern neuroscience has for our broader society. The keynote speaker will be Tom Insel, Director of the US National Institute of Mental Health, and prominent international neuroscientists will discuss the how new insights into the development and function of the brain and nervous system are impacting the arts, education, economics, philosophy, health and our understanding of ourselves as individuals and as members of society.

About the Organizers:

For more than 20 years, Neuron has been one of the most influential and relied upon journals in the field of neuroscience. Neuron publishes research on topics spanning the breadth of neuroscience, from molecular and physiological mechanisms of development and function to diseases of the nervous system and higher-level systems and cognitive studies. In addition to seminal research findings, Neuron also publishes a broad array of review material, including Previews, Minireviews, and Reviews, whose content is aimed at providing broad-spectrum coverage of recent developments in neuroscience, making Neuron a "must-read" for all neuroscientists. (www.neuron.org)

Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the scientific community it serves. Cell Press primary research journals include the flagship journal Cell, as well as Neuron, Immunity, Molecular Cell, Developmental Cell, Cancer Cell, Current Biology, Structure, Chemistry & Biology, Cell Metabolism, Cell Host & Microbe, Cell Stem Cell and, new to Cell Press in 2008, The American Journal of Human Genetics. Cell Press also publishes the Trends family of reviews journals, including Trends in Cell Biology, Trends in Neurosciences, and Trends in Cognitive Sciences. (www.cellpress.com)

The Fondation IPSEN (Paris), created in 1983, has two objectives, the distribution of knowledge, and encouraging the exploration of emerging areas of research. To fulfill these commitments the foundation organizes series of international meetings (among them, the Colloques Médecine et Recherche in Neurosciences, Alzheimer's disease, Endocrinology, Cancer Science, Longevity, and the Vascular Tree). It also awards annual prizes in recognition of outstanding scientific achievements and publishes various reports, books, newsletters, etc.

Over the past twenty-four years, the Fondation IPSEN has established its place in the scientific and medical landscape and intends to continue to be at the forefront in forming links, initiating multidisciplinary exchanges and contributing to the spread of knowledge, with time, intelligence, goodwill and above all, the collaboration of leaders in current biomedical research. (http://www.ipsen.com/fondation)

The Massachusetts General Hospital (MGH) has long been a leader in successfully bridging cutting edge science with state-of-the-art clinical medicine. Over the past several decades, MGH trainees have played a leading role in biomedical science. In this tradition, the MGH Cardiovascular Research Center (CVRC) is dedicated to advancing human health through fundamental scientific advances in the mechanisms of cardiovascular disease and related metabolic disorders. Both the MGH and the CVRC are committed to recruiting, training, and mentoring the next generation of international leaders in cardiovascular science and medicine.

To accomplish these goals, the CVRC has forged joint programs with leading scientific institutions, including the Harvard Stem Cell Institute (HSCI), the Broad Institute of Harvard-MIT, the NIH Framingham study and the Jean LeDucq Foundation. At the same time, the CVRC is establishing collaborative research programs with leading institutions in the private sector, capitalizing on its dual expertise in studies in humans and model organisms, along with a cutting-edge genetics, genotyping, and unique patient subsets. (www.mgh.harvard.edu/cvrc/

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.